Cargando…
Genetic heterogeneity during breast cancer progression in young patients
BACKGROUND: Because a number of years may be required for normal cells to develop into carcinoma, genes involved in tumorigenesis and progression might differ among breast cancers in young women and those in older women. The present study sought to analyze subclonality during breast cancer evolution...
Autores principales: | Hagio, Kanako, Hatanaka, Kanako C., Amano, Toraji, Matsuno, Yoshihiro, Hatanaka, Yutaka, Yamashita, Hiroko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569715/ https://www.ncbi.nlm.nih.gov/pubmed/34736091 http://dx.doi.org/10.1016/j.breast.2021.10.011 |
Ejemplares similares
-
PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer
por: Ishida, Naoko, et al.
Publicado: (2018) -
p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors
por: Yamamoto, Mitsugu, et al.
Publicado: (2014) -
Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer
por: Mitamura, Takashi, et al.
Publicado: (2022) -
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers
por: Hagio, Kanako, et al.
Publicado: (2023) -
Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer
por: Hagio, Kanako, et al.
Publicado: (2021)